Peroxisome-proliferator-activated receptors and cancers: complex stories
Liliane Michalik, Béatrice Desvergne, Walter Wahli · Nature reviews. Cancer · 2004
Cited by 573 works. doi:10.1038/nrc1254
Authors
References
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
- Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
- Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome Proliferators
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
- A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
- Roles of PPARs in health and disease
- Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
- Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension